Enhanced antigen-specific antibody and cytokine responses when targeting antigen to human FcGAMMA receptor type I using an anti-human FcGAMMA receptor type I-streptavidin fusion protein in an adjuvant-free system.

Source:http://linkedlifedata.com/resource/pubmed/id/16304730

Download in:

View as

General Info

PMID
16304730